To Bouncer Bull (sorry, Bill): You said:
I have addressed the more serious point about how the cancer may be transferred in a previous post, to which as of now there has been no contradiction: the carcinogen will block the ox phos pathway in response to which the cell up/down regulates the cell's gene expression so as to shift to glycolysis as a means of survival (remember all cancer cells are still alive, even though aberrant).
Carcinogens don't block this pathway, you have insufficinet evidence to make this claim.
Mitosis at that point will reproduce the transformed cells, which will continue (as in metastasis) even without any further carcinogenic action.
STOP - how can cell division reproduce transformed cells unless the cells DNA has been in some way altered ?
until a superior dehydrogenator such as parabenzoquinone arrives to correct the problem (if it ever does) and thereby restore oxidative phosphorylation.
We see this in our lab using PBLs and conducting a glucose oxidase and hexokinase assay (these Sigma Diagnostic kits are available easily for would be replicators) before and after administering the quinone, which shows a slow down in the uptake of glucose after the administration. (we have not published this yet, but will probably present initially at a conference in London in September).
Which can be explained without resorting to unprove theories of carcinogenesis
In my view this is a better explanation than the traditional multistage explanation for carcinogenesis, which leaves out the vital steps re metabolic change. These are the steps which Szent Gyorgii added in around 1960, but which William Koch had deduced and proven in clinical practice in the first decades of the 20thC.
and your view is not supported by the evidence
Yes, I said in clinical practice:
The cancer mortality figures for Detroit 1920 to 1929 show a 23 percent fall, in a decade where every other major US city was recording increases of up to 32 percent in annual cancer mortality. Koch's quinone-based reagents were the principal cancer treatment modality in Detroit at that time.
).
.
